Longboard Pharmaceuticals, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Longboard Pharmaceuticals has been acquired by H. Lundbeck A/S for $60 per share, completing the merger on December 2, 2024.